TPP decreases melanoma tumor growth rate when administered via hydrogel. by Kyle C. Kloepping (9928265)

5-fluorouracil decreases rates of persistent and reappearing actinic keratoses: The VAKCC Trial by Moniyka Sachar (9399032)

Equation fitting of physiological rates: clearance rate (CR; A, n = 60), respiration rate (RR; B, N = 74) and excretion rate (ER; C, n = 78) for sea scallops, <i>Placopecten magell... by Emilien Pousse (14664318)

Subjects:

Virus from obese mice decreased infectivity to mosquitoes and lower transmission rates. by James Weger-Lucarelli (603766)

The identified significant high-rate spatial-temporal clusters of new detected leprosy cases in Yunnan, China, 2011–2020. by Xiaohua Chen (257762)

Study Data. by Jonathan S. Jahr (2709088)

“…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”

Study outcomes. by Jonathan S. Jahr (2709088)

“…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”

Patient characteristics. by Jonathan S. Jahr (2709088)

“…A total of 103 subjects were evaluated, of whom 38 received intravenous dexamethasone (either 4 mg, 8 mg, or 10 mg) during their anesthetic course and 65 patients had not received dexamethasone. The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”

Spatial information of excitatory neurons in APP/PS1 mice are decreased in dCA1 and vCA1. by Udaysankar Chockanathan (18510288)

“…The spatial information in dCA1 was significantly larger than circularly shuffled spike trains with similar mean firing rates for C57BL/6 mice (mean ± std: empirical = 0.134 ± 0.050, shuffled = 0.123 ± 0.035, p < 0.005, two-sided Wilcoxon rank-sum test, n_empirical = 229 units from 5 recording sessions, n_shuffled = 22900 simulated units from 5 recording sessions), but not for APP/PS1 mice (mean ± std: empirical = 0.132 ± 0.054, shuffled = 0.124 ± .054, p = 0.13, two-sided Wilcoxon rank-sum test, n_empirical = 124 units from 4 recording sessions, n_shuffled = 12400 simulated units from 4 recording sessions). …”

Heart rate variability. by Minako Kaido (309626)

Subjects:

Rates of cataract surgical procedures per 10,000 people according to region. by Arthur Gustavo Fernandes (5766305)

Cardiomyocyte apoptosis rate in the CCM group. by Qingqing Hao (5464070)

Subjects:

Cardiomyocyte apoptosis rate in the Sham group. by Qingqing Hao (5464070)

Subjects:

Cardiomyocyte apoptosis rate in the three groups. by Qingqing Hao (5464070)

Subjects:

Cardiomyocyte apoptosis rate in the HF group. by Qingqing Hao (5464070)

Subjects:

The results of KEGG enrichment analysis (Annotation: Circles represent each pathway, and the redder the color, the larger the circle, and the more important it is). by Lin Zhou (141050)

Raw data used to calculate the statistical significances stated in the result section. by Tom Adriaenssens (397863)

Subjects:

Occurrence rate of eye contact. by Atsushi Nakazawa (15892700)

Subjects:

The effect of instilling the ophthalmic solution on the LF/HF ratio and typical cases of fluctuations in the LF/HF ratio over time in the DE and non-DE groups. by Minako Kaido (309626)

Subjects:

Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

“…Implementing rapid vaccination after detecting the virus in ten individuals and achieving 40% coverage could reduce infection rates by 82%, preventing 139,805 cases. Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”